Skip to content
healthcare.dev

cisatracurium besylate

NDC 0781-3150, cisatracurium besylate, injection, from Sandoz Inc.

Product NDC
0781-3150
Status
Listed
Labeler
Sandoz Inc
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA200154
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0781-3150 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE2 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
0781-3150-950078131509510 BOX in 1 CARTON (0781-3150-95) / 1 VIAL in 1 BOX (0781-3150-75) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/291a55dd-ab45-4660-b513-4ecb729eb051

Use it

Look up 0781-3150 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0781-3150 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0781-3150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.